X-Linked Agammaglobulinemia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which X-Linked Agammaglobulinemia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07328178

Analysis of the Role of IgE Proteoforms in Health and Disease

The goal of this observational study is to evaluate the role of IgE proteoforms in healthy volunteers and in patients with type I allergy, patients with chronic…

Belgium200 participantsStarted 2025-01-01

Treatment: Blood sample collection

All recent trials (17 shown)

Active — Not RecruitingPhase 2

NCT01821781

Immune Disorder HSCT Protocol

This study hypothesizes that a reduced intensity immunosuppressive preparative regimen will establish engraftment of donor hematopoietic cells with acceptable e…

United States20 participantsStarted 2013-04-29

Treatment: Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan

Active — Not RecruitingNot Applicable

NCT05321407

COVID-19 Vaccine Responses in PIDD Subjects

The goal of our study is to assess the cellular immune responses of participants with antibody deficiency disease before and after immunization with SARS-CoV-2…

United States100 participantsStarted 2021-09-30

X-Linked Agammaglobulinemia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Analysis of the Role of IgE Proteoforms in Health and Disease

All recent trials (17 shown)

Immune Disorder HSCT Protocol

COVID-19 Vaccine Responses in PIDD Subjects

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Analysis of the Role of IgE Proteoforms in Health and Disease

All recent trials (17 shown)

Immune Disorder HSCT Protocol

COVID-19 Vaccine Responses in PIDD Subjects

Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases

Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older

Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Pr…

Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects

A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency

Mutation of the BTK Gene and Genotype-phenotype Correlation of Chinese Patients With X-Linked Agammaglobulinemia

A Clinical Study of Intravenous Immunoglobulin

Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency

Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy

Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds

Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders